{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:59:48Z","timestamp":1767999588537,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00345-019-02720-y","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T04:55:27Z","timestamp":1556600127000},"page":"1023-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond medications: office-based procedures for benign prostatic obstruction"],"prefix":"10.1007","volume":"37","author":[{"given":"Phuong U.","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0111-4961","authenticated-orcid":false,"given":"Amanda S. J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"1","key":"2720_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2015.03.021","volume":"86","author":"LA Mynderse","year":"2015","unstructured":"Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Cedano ER, Woodrum DA, Dixon CM, Larson TR (2015) Rezum system water vapor treatment for lower urinary tract symptoms\/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology 86(1):122\u2013127. \n                    https:\/\/doi.org\/10.1016\/j.urology.2015.03.021","journal-title":"Urology"},{"issue":"5","key":"2720_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.urology.2015.05.046","volume":"86","author":"C Dixon","year":"2015","unstructured":"Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Mynderse L, Larson T (2015) Efficacy and safety of rezum system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 86(5):1042\u20131047. \n                    https:\/\/doi.org\/10.1016\/j.urology.2015.05.046","journal-title":"Urology"},{"key":"2720_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/RRU.S119596","volume":"8","author":"CM Dixon","year":"2016","unstructured":"Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Larson TR, Mynderse LA (2016) Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 8:207\u2013216. \n                    https:\/\/doi.org\/10.2147\/RRU.S119596","journal-title":"Res Rep Urol"},{"issue":"5","key":"2720_CR4","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG (2016) Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 195(5):1529\u20131538. \n                    https:\/\/doi.org\/10.1016\/j.juro.2015.10.181","journal-title":"J Urol"},{"issue":"5","key":"2720_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.acuro.2014.05.010","volume":"39","author":"LM Sanchez-Gomez","year":"2015","unstructured":"Sanchez-Gomez LM, Polo-deSantos M, Gomez-Sancha F, Luengo-Matos S (2015) Efficacy and safety of the urolift(R) system for the treatment of benign prostate hyperplasia symptoms: systematic review. Actas Urol Esp 39(5):311\u2013319. \n                    https:\/\/doi.org\/10.1016\/j.acuro.2014.05.010","journal-title":"Actas Urol Esp"},{"issue":"6","key":"2720_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.21037\/atm.2016.01.29","volume":"4","author":"P Jones","year":"2016","unstructured":"Jones P, Rai BP, Aboumarzouk OM, Somani BK (2016) Urolift: a new chapter in benign prostate hyperplasia (BPH) therapy. Ann Transl Med 4(6):116. \n                    https:\/\/doi.org\/10.21037\/atm.2016.01.29","journal-title":"Ann Transl Med"},{"issue":"4","key":"2720_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.eururo.2014.10.031","volume":"67","author":"M Perera","year":"2015","unstructured":"Perera M, Roberts MJ, Doi SA, Bolton D (2015) Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 67(4):704\u2013713. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2014.10.031","journal-title":"Eur Urol"},{"issue":"3","key":"2720_CR8","first-page":"7772","volume":"22","author":"CG Roehrborn","year":"2015","unstructured":"Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P (2015) Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22(3):7772\u20137782","journal-title":"Can J Urol"},{"key":"2720_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/MDER.S60780","volume":"9","author":"TA McNicholas","year":"2016","unstructured":"McNicholas TA (2016) Benign prostatic hyperplasia and new treatment options\u2014a critical appraisal of the UroLift system. Med Devices (Auckl) 9:115\u2013123. \n                    https:\/\/doi.org\/10.2147\/MDER.S60780","journal-title":"Med Devices (Auckl)"},{"issue":"2","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bju.12982","volume":"116","author":"F Porpiglia","year":"2015","unstructured":"Porpiglia F, Fiori C, Bertolo R, Garrou D, Cattaneo G, Amparore D (2015) Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1\u00a0year of follow-up. BJU Int 116(2):278\u2013287. \n                    https:\/\/doi.org\/10.1111\/bju.12982","journal-title":"BJU Int"},{"issue":"1","key":"2720_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.euf.2018.04.009","volume":"4","author":"J Marcon","year":"2018","unstructured":"Marcon J, Magistro G, Stief CG, Grimm T (2018) What\u2019s new in TIND? Eur Urol Focus 4(1):40\u201342. \n                    https:\/\/doi.org\/10.1016\/j.euf.2018.04.009","journal-title":"Eur Urol Focus"},{"issue":"1","key":"2720_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/bju.14141","volume":"122","author":"F Porpiglia","year":"2018","unstructured":"Porpiglia F, Fiori C, Bertolo R, Giordano A, Checcucci E, Garrou D, Cattaneo G, De Luca S, Amparore D (2018) 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction. BJU Int 122(1):106\u2013112. \n                    https:\/\/doi.org\/10.1111\/bju.14141","journal-title":"BJU Int"},{"issue":"6","key":"2720_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4111\/icu.2017.58.6.447","volume":"58","author":"K Sethi","year":"2017","unstructured":"Sethi K, Bozin M, Jabane T, McMullin R, Cook D, Forsyth R, Dodds L, Putra LJ (2017) Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: an underutilized procedure? Investig Clin Urol 58(6):447\u2013452. \n                    https:\/\/doi.org\/10.4111\/icu.2017.58.6.447","journal-title":"Investig Clin Urol"},{"issue":"Suppl 2","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.21037\/tau.2017.04.19","volume":"6","author":"A Silagy","year":"2017","unstructured":"Silagy A, Merrett C, Agarwal D (2017) Initial experience with Allium stent in the management of bulbar urethral stricture. Transl Androl Urol 6(Suppl 2):S88\u2013S91. \n                    https:\/\/doi.org\/10.21037\/tau.2017.04.19","journal-title":"Transl Androl Urol"},{"issue":"8","key":"2720_CR15","first-page":"601","volume":"69","author":"Z Bahouth","year":"2016","unstructured":"Bahouth Z, Meyer G, Yildiz G, Nativ O, Moskovitz B (2016) Update in urethral stents. Arch Esp Urol 69(8):601\u2013606","journal-title":"Arch Esp Urol"},{"issue":"3","key":"2720_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/end.2015.0593","volume":"30","author":"G Yildiz","year":"2016","unstructured":"Yildiz G, Bahouth Z, Halachmi S, Meyer G, Nativ O, Moskovitz B (2016) Allium TPS\u2014a new prostatic stent for the treatment of patients with benign prostatic obstruction: the first report. J Endourol 30(3):319\u2013322. \n                    https:\/\/doi.org\/10.1089\/end.2015.0593","journal-title":"J Endourol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02720-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:09:38Z","timestamp":1588028978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02720-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02720-y","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PUT has no conflicts of interest. ASJC has received an honorarium from Astellas Pharma Australia Pty Ltd for speaking at a symposium.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}